BR112015024014A2 - vacina conjugada - Google Patents
vacina conjugadaInfo
- Publication number
- BR112015024014A2 BR112015024014A2 BR112015024014A BR112015024014A BR112015024014A2 BR 112015024014 A2 BR112015024014 A2 BR 112015024014A2 BR 112015024014 A BR112015024014 A BR 112015024014A BR 112015024014 A BR112015024014 A BR 112015024014A BR 112015024014 A2 BR112015024014 A2 BR 112015024014A2
- Authority
- BR
- Brazil
- Prior art keywords
- meningitidis
- saccharide
- serogroup
- conjugate vaccine
- capsular
- Prior art date
Links
- 108010060123 Conjugate Vaccines Proteins 0.000 title abstract 4
- 229940031670 conjugate vaccine Drugs 0.000 title abstract 4
- 150000001720 carbohydrates Chemical class 0.000 abstract 8
- 241000588650 Neisseria meningitidis Species 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 230000003053 immunization Effects 0.000 abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 abstract 2
- 208000034762 Meningococcal Infections Diseases 0.000 abstract 1
- 229960003983 diphtheria toxoid Drugs 0.000 abstract 1
- 229960000814 tetanus toxoid Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Virology (AREA)
Abstract
1 / 1 resumo âvacina conjugadaâ o pedido descreve um mã©todo de imunizar contra infecã§ã£o por neisseria meningitidis compreendendo as etapas de: a) imunizar um paciente humano em uma primeira idade de entre 0 e 11 meses com uma vacina conjugada de sacarãdeo bacteriano compreendendo pelo menos um, dois ou trãªs sacarãdeo(s) bacteriano(s) separadamente conjugado(s) com uma proteãna carreadora para formar pelo menos um, dois ou trãªs conjugado(s) de sacarãdeo bacteriano; e b) imunizar o paciente humano em uma segunda idade de entre 12 e 24 meses com uma vacina conjugada contra neisseria meningitidis compreendendo pelo menos dois sacarãdeos capsulares selecionados do grupo que consiste em sacarãdeo capsular de n. meningitidis de sorogrupo a (mena), sacarãdeo capsular de n. meningitidis de sorogrupo c (menc), sacarãdeo capsular de n. meningitidis de sorogrupo w135 (menw135), e sacarãdeo capsular de n. meningitidis de sorogrupo y (meny) conjugados separadamente com uma proteãna carreadora, em que a vacina conjugada contra neisseria meningitidis ã© coadministrada com uma vacina compreendendo toxã³ide da difteria e toxã³ide do tã©tano.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361802918P | 2013-03-18 | 2013-03-18 | |
US201361874008P | 2013-09-05 | 2013-09-05 | |
PCT/EP2014/055355 WO2014147044A1 (en) | 2013-03-18 | 2014-03-17 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015024014A2 true BR112015024014A2 (pt) | 2017-07-18 |
Family
ID=50336313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015024014A BR112015024014A2 (pt) | 2013-03-18 | 2014-03-17 | vacina conjugada |
Country Status (21)
Country | Link |
---|---|
US (1) | US11883478B2 (pt) |
EP (1) | EP2976101B1 (pt) |
JP (2) | JP6747968B2 (pt) |
KR (1) | KR20150121265A (pt) |
CN (1) | CN105188743A (pt) |
AU (1) | AU2014234408B2 (pt) |
BE (1) | BE1021934B1 (pt) |
BR (1) | BR112015024014A2 (pt) |
CA (1) | CA2903322C (pt) |
CY (1) | CY1123600T1 (pt) |
DK (1) | DK2976101T3 (pt) |
EA (1) | EA034380B1 (pt) |
ES (1) | ES2830035T3 (pt) |
HU (1) | HUE051592T2 (pt) |
IL (1) | IL241096B (pt) |
MX (1) | MX2015013401A (pt) |
PL (1) | PL2976101T3 (pt) |
PT (1) | PT2976101T (pt) |
SG (2) | SG10201710137QA (pt) |
SI (1) | SI2976101T1 (pt) |
WO (1) | WO2014147044A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109890413B (zh) | 2016-09-02 | 2024-04-16 | 赛诺菲巴斯德股份有限公司 | 脑膜炎奈瑟氏菌疫苗 |
EP3706787A4 (en) * | 2017-11-06 | 2021-10-20 | OZQ Pty Ltd | VACCINE |
CN110652585B (zh) * | 2018-10-26 | 2023-05-26 | 武汉博沃生物科技有限公司 | 多糖-蛋白缀合物免疫制剂及其制备与应用 |
BR112022008761A2 (pt) * | 2019-11-22 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Dosagem e administração de uma vacina de glicoconjugado de sacarídeo |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018637B2 (en) | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
CA2435681C (en) * | 2001-01-23 | 2011-06-21 | Aventis Pasteur | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
GB0409745D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
CA2611960C (en) | 2005-06-27 | 2015-05-05 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates |
AU2012203419B2 (en) * | 2005-06-27 | 2014-06-26 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
US20080305127A1 (en) * | 2005-12-23 | 2008-12-11 | Glaxosmithkline Biologicals S.A. | Conjugate Vaccines |
TR201807355T4 (tr) | 2006-03-22 | 2018-06-21 | Glaxosmithkline Biologicals Sa | Meningokokkal konjugatlarla immünizasyon rejimleri. |
-
2014
- 2014-03-17 KR KR1020157030027A patent/KR20150121265A/ko not_active IP Right Cessation
- 2014-03-17 ES ES14711232T patent/ES2830035T3/es active Active
- 2014-03-17 BR BR112015024014A patent/BR112015024014A2/pt not_active Application Discontinuation
- 2014-03-17 PT PT147112320T patent/PT2976101T/pt unknown
- 2014-03-17 WO PCT/EP2014/055355 patent/WO2014147044A1/en active Application Filing
- 2014-03-17 DK DK14711232.0T patent/DK2976101T3/da active
- 2014-03-17 SG SG10201710137QA patent/SG10201710137QA/en unknown
- 2014-03-17 SI SI201431706T patent/SI2976101T1/sl unknown
- 2014-03-17 JP JP2016503631A patent/JP6747968B2/ja active Active
- 2014-03-17 US US14/777,985 patent/US11883478B2/en active Active
- 2014-03-17 BE BE2014/0175A patent/BE1021934B1/fr active
- 2014-03-17 CA CA2903322A patent/CA2903322C/en active Active
- 2014-03-17 PL PL14711232T patent/PL2976101T3/pl unknown
- 2014-03-17 CN CN201480016792.XA patent/CN105188743A/zh active Pending
- 2014-03-17 EP EP14711232.0A patent/EP2976101B1/en not_active Revoked
- 2014-03-17 HU HUE14711232A patent/HUE051592T2/hu unknown
- 2014-03-17 SG SG11201506810RA patent/SG11201506810RA/en unknown
- 2014-03-17 AU AU2014234408A patent/AU2014234408B2/en active Active
- 2014-03-17 EA EA201591468A patent/EA034380B1/ru not_active IP Right Cessation
- 2014-03-17 MX MX2015013401A patent/MX2015013401A/es unknown
-
2015
- 2015-09-03 IL IL241096A patent/IL241096B/en active IP Right Grant
-
2019
- 2019-04-04 JP JP2019072050A patent/JP2019142898A/ja active Pending
-
2020
- 2020-11-19 CY CY20201101097T patent/CY1123600T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SI2976101T1 (sl) | 2021-01-29 |
IL241096B (en) | 2021-05-31 |
BE1021934B1 (fr) | 2016-01-27 |
US11883478B2 (en) | 2024-01-30 |
AU2014234408B2 (en) | 2017-04-20 |
WO2014147044A1 (en) | 2014-09-25 |
EA034380B1 (ru) | 2020-01-31 |
ES2830035T3 (es) | 2021-06-02 |
JP2019142898A (ja) | 2019-08-29 |
PT2976101T (pt) | 2020-11-12 |
IL241096A0 (en) | 2015-11-30 |
DK2976101T3 (da) | 2020-11-23 |
EP2976101A1 (en) | 2016-01-27 |
JP2016515539A (ja) | 2016-05-30 |
HUE051592T2 (hu) | 2021-03-01 |
CY1123600T1 (el) | 2022-03-24 |
CA2903322C (en) | 2023-09-05 |
SG10201710137QA (en) | 2018-01-30 |
AU2014234408A1 (en) | 2015-10-22 |
CN105188743A (zh) | 2015-12-23 |
PL2976101T3 (pl) | 2021-03-08 |
JP6747968B2 (ja) | 2020-08-26 |
SG11201506810RA (en) | 2015-10-29 |
CA2903322A1 (en) | 2014-09-25 |
EP2976101B1 (en) | 2020-08-19 |
KR20150121265A (ko) | 2015-10-28 |
US20160279225A1 (en) | 2016-09-29 |
MX2015013401A (es) | 2016-01-08 |
EA201591468A1 (ru) | 2016-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018000087A2 (pt) | composições imunogênicas que compreendem antígenos de sacarídeos capsulares conjugados, kits que compreendem as mesmas e usos das mesmas | |
BRPI0612656A8 (pt) | composição imunogênica, vacina, kit de vacina para a administração concomitante ou sequencial, processo para a produção da vacina, método de imunização de um hospedeiro humano contra doença causada por infecção de neisseria meningitidis, e, uso da composição imunogênica | |
BR112020011414B8 (pt) | Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae | |
BRPI0620193B8 (pt) | composição imunogênica e vacina a compreendendo, bem como processo para preparar a vacina | |
BRPI0607374A2 (pt) | vacinas de vesìculas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis | |
BRPI0813307B8 (pt) | composição imunogênica, vacina, e, processo para fabricar a vacina | |
BR112014018815A8 (pt) | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis | |
BR112021011961A8 (pt) | Composições compreendendo conjugados de polissacarídeo-proteína de streptococcus pneumoniae e métodos de uso dos mesmos | |
CR10123A (es) | Vacuna. | |
BR112016015525A2 (pt) | composições imunogênicas compreendendo antígenos sacarídeos capsulares conjugados e uso | |
GB201101665D0 (en) | Immunogenic compositions | |
CY1123600T1 (el) | Μεθοδος θεραπειας | |
BR112015008418A2 (pt) | uso de uma composição imunogênica, composição imunogênica, e, métodos para intensificar atividade opsônica mediada por anticorpo contra um sorotipo alvejado de streptococcus pneumoniae em um indivíduo e para imunizar um hospedeiro humano contra doenças causadas por infecção por streptococcus pneumoniae | |
AR090294A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
MX2014014067A (es) | Conjugado de serogrupo x de meningococo. | |
BR112015004593A2 (pt) | composições imunogênicas | |
BR112019001995A2 (pt) | composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína | |
BRPI0411875A (pt) | método de imunização contra os sorogrupos a e c de neisseria meningitidis | |
BRPI0516770A (pt) | vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente | |
BRPI0515125A (pt) | conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina | |
WO2018042017A3 (en) | Vaccines for neisseria gonorrhoeae | |
EA201592040A1 (ru) | Иммуногенная композиция для применения в терапии | |
BR112023023671A2 (pt) | Composições imunogênicas compreendendo antígenos de sacarídeo capsular conjugados e usos dos mesmos | |
AR095579A1 (es) | Procedimiento de inmunización | |
MX2013002841A (es) | Composiciones inmunogenas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |